@hack2abi What’s your take on holding this stock considering there is no expected NIM expansion or operating leverage to play out in the near term. Credit cost base is still unfavourable for the next few quarters.
I personally see more anti-thesis than thesis in the bank post the reverse merger.
| Subscribe To Our Free Newsletter |
